Search
for

    Research

    5 / 532 results

      research Treatment of Alopecia Areata with Anti-Interferon-γ Antibodies

      16 citations , November 2005 in “Journal of Investigative Dermatology Symposium Proceedings”
      This study found that intramuscular anti-IFN-γ significantly stabilized and promoted hair regrowth in alopecia areata patients with patchy, progressive hair loss, whereas those with total baldness showed more limited improvement.

      research The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside

      144 citations , November 2020 in “Frontiers in immunology”
      This study summarizes how the IL-23/IL-17 axis contributes to inflammatory skin diseases like psoriasis and highlights that biologics targeting this pathway, including monoclonal antibodies against IL-23 and IL-17, have shown efficacy in clinical trials for these conditions.

      research Editorial: Prevention and treatment of skin diseases

      January 2026 in “Frontiers in Pharmacology”
      This research highlights the potential of personalized medicine and advanced therapeutic strategies, including 3D biomaterials and natural products, to enhance wound healing and skin care, while also acknowledging the limitations and safety concerns associated with these innovations.

      research Targeting the Wnt pathways for therapies

      112 citations , January 2014 in “Molecular and cellular therapies”
      This review summarizes the current understanding of Wnt signaling in relation to its roles in tissue regeneration and cancer progression and discusses recent medical advancements targeting this pathway for therapeutic purposes.

      research Pharmacotherapy for Keloids and Hypertrophic Scars

      April 2024 in “International journal of molecular sciences”
      This source reports that for treating keloids and hypertrophic scars, combination pharmacotherapy targeting multiple sites is generally more effective than using a single drug, though outcomes of individual therapies vary and the development of satisfying treatments is ongoing.